COGZF Stock — Cogstate Limited

Cogstate Limited (COGZF)

Updated October 15, 2026.

COGZF is a Stock. its trailing-12-month yield is 2.30%. Total return is 826.4% over the past 16.6 years, 41.3 points ahead of SPY at 785.1%.

Cogstate Limited is a neuroscience solutions company that develops and commercializes digital brain health assessments used primarily in clinical trials for drug development and disease monitoring. The company provides cognitive assessment tools, data quality services, remote assessment capabilities, and scientific consulting across therapeutic areas including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, serving biopharmaceutical companies, academic institutions, and healthcare providers. The security does not currently have an established distribution schedule.

COGZF performance versus SPY

Price and return data through 2026-10-15.

Total return is 826.4% over the past 16.6 years, 41.3 points ahead of SPY at 785.1%. Over the past year its total return — price change plus distributions reinvested — is 63.2%. Its deepest 1-year drawdown was 35.2%.

COGZF key facts

Asset type

Stock

Asset class

Equity

Inception date

03/25/2010

Distribution frequency

None

Trailing yield

2.30%

Last close

$2.48 (as of 2026-10-15)

Market cap

$426,532,762

Average volume

0.0

Dividend

$0.0287

Ex-dividend date

08/24/2026

Payment date

09/22/2026

Beta

0.212

Payout ratio

19.5%

P/E ratio

35.43

Forward P/E

22.4719

EPS

$0.07

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (2.30%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

COGZF risks and drawbacks

The deepest 1-year drawdown on record here is 35.2%.

Who may consider COGZF — and who may not

It is a weaker fit for investors who need monthly cash flow (COGZF does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on COGZF

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions